S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Stock market today: Wall Street drifts higher, marking 4th winning week for S&P 500
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 EV Stocks You Need To Have On Your Watchlist
3 Mid Caps You Haven't Heard Of But Need To Know About
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Why Turkey's currency is crashing after Erdogan got reelected
Even at $2,000+ Per Share, These 3 Stocks Are Deals
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Stock market today: Wall Street drifts higher, marking 4th winning week for S&P 500
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 EV Stocks You Need To Have On Your Watchlist
3 Mid Caps You Haven't Heard Of But Need To Know About
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Why Turkey's currency is crashing after Erdogan got reelected
Even at $2,000+ Per Share, These 3 Stocks Are Deals
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Stock market today: Wall Street drifts higher, marking 4th winning week for S&P 500
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 EV Stocks You Need To Have On Your Watchlist
3 Mid Caps You Haven't Heard Of But Need To Know About
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Why Turkey's currency is crashing after Erdogan got reelected
Even at $2,000+ Per Share, These 3 Stocks Are Deals
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Stock market today: Wall Street drifts higher, marking 4th winning week for S&P 500
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
3 EV Stocks You Need To Have On Your Watchlist
3 Mid Caps You Haven't Heard Of But Need To Know About
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Why Turkey's currency is crashing after Erdogan got reelected
Even at $2,000+ Per Share, These 3 Stocks Are Deals
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Will NIO Partake In China's Economic Awakening?
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
NASDAQ:ANGO

AngioDynamics (ANGO) Stock Forecast, Price & News

$10.79
+0.80 (+8.01%)
(As of 06/9/2023 ET)
Compare
Today's Range
$10.03
$11.14
50-Day Range
$8.29
$10.34
52-Week Range
$8.18
$24.74
Volume
1.37 million shs
Average Volume
344,625 shs
Market Capitalization
$423.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.00

AngioDynamics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
122.4% Upside
$24.00 Price Target
Short Interest
Healthy
2.01% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.99
Upright™ Environmental Score
News Sentiment
0.83mentions of AngioDynamics in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.05) to $0.02 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.71 out of 5 stars

Medical Sector

54th out of 987 stocks

Surgical & Medical Instruments Industry

4th out of 96 stocks


ANGO stock logo

About AngioDynamics (NASDAQ:ANGO) Stock

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.

Receive ANGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter.

ANGO Stock News Headlines

"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Why Shares of AngioDynamics Rose Friday
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
AngioDynamics (NASDAQ: ANGO)
AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update
AngioDynamics (NASDAQ:ANGO) Issues FY 2023 Earnings Guidance
See More Headlines

ANGO Price History

ANGO Company Calendar

Last Earnings
3/30/2023
Today
6/10/2023
Next Earnings (Estimated)
7/11/2023
Fiscal Year End
5/31/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:ANGO
CUSIP
03475V10
Employees
800
Year Founded
1988

Price Target and Rating

Average Stock Price Forecast
$24.00
High Stock Price Forecast
$35.00
Low Stock Price Forecast
$13.00
Forecasted Upside/Downside
+122.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-26,550,000.00
Pretax Margin
-11.74%

Debt

Sales & Book Value

Annual Sales
$316.22 million
Cash Flow
$0.81 per share
Book Value
$10.96 per share

Miscellaneous

Free Float
37,313,000
Market Cap
$423.40 million
Optionable
Optionable
Beta
0.60

Social Links


Key Executives

  • James Christopher Clemmer
    President, Chief Executive Officer & Director
  • David D. Helsel
    SVP-Global Operations, Research & Development
  • Stephen A. TrowbridgeStephen A. Trowbridge
    Chief Financial Officer & Executive Vice President
  • Kim L. Seabury
    Senior Vice President-Information Technology
  • Juan Carlos Serna
    Senior VP-Scientific & Clinical Affairs













ANGO Stock - Frequently Asked Questions

Should I buy or sell AngioDynamics stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ANGO shares.
View ANGO analyst ratings
or view top-rated stocks.

What is AngioDynamics' stock price forecast for 2023?

1 equities research analysts have issued twelve-month price objectives for AngioDynamics' stock. Their ANGO share price forecasts range from $13.00 to $35.00. On average, they expect the company's stock price to reach $24.00 in the next twelve months. This suggests a possible upside of 122.4% from the stock's current price.
View analysts price targets for ANGO
or view top-rated stocks among Wall Street analysts.

How have ANGO shares performed in 2023?

AngioDynamics' stock was trading at $13.77 at the start of the year. Since then, ANGO stock has decreased by 21.6% and is now trading at $10.79.
View the best growth stocks for 2023 here
.

When is AngioDynamics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 11th 2023.
View our ANGO earnings forecast
.

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) announced its quarterly earnings data on Thursday, March, 30th. The medical instruments supplier reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.02. The medical instruments supplier had revenue of $80.70 million for the quarter, compared to analyst estimates of $83.20 million. AngioDynamics had a negative trailing twelve-month return on equity of 0.71% and a negative net margin of 11.13%. The business's revenue for the quarter was up 9.1% compared to the same quarter last year. During the same period in the prior year, the business earned $0.03 EPS.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics issued an update on its FY 2023 earnings guidance on Thursday, June, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $338.00 million-$339.00 million, compared to the consensus revenue estimate of $338.83 million.

What is James C. Clemmer's approval rating as AngioDynamics' CEO?

34 employees have rated AngioDynamics Chief Executive Officer James C. Clemmer on Glassdoor.com. James C. Clemmer has an approval rating of 50% among the company's employees. This puts James C. Clemmer in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 47.0% of employees surveyed would recommend working at AngioDynamics to a friend.

What other stocks do shareholders of AngioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include General Electric (GE), Intel (INTC), Oasis Petroleum (OAS), Advanced Micro Devices (AMD), Freeport-McMoRan (FCX), Amicus Therapeutics (FOLD), Rigel Pharmaceuticals (RIGL), Accuray (ARAY), Celldex Therapeutics (CLDX) and Chimerix (CMRX).

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

Who are AngioDynamics' major shareholders?

AngioDynamics' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (18.57%), Victory Capital Management Inc. (9.86%), Dimensional Fund Advisors LP (6.33%), State Street Corp (5.29%), Systematic Financial Management LP (3.58%) and Paradigm Capital Management Inc. NY (2.22%). Insiders that own company stock include Chad Thomas Campbell, Dave Helsel, James C Clemmer, James C Clemmer, Scott Centea, Stephen A Trowbridge and Wesley Johnson.
View institutional ownership trends
.

How do I buy shares of AngioDynamics?

Shares of ANGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AngioDynamics' stock price today?

One share of ANGO stock can currently be purchased for approximately $10.79.

How much money does AngioDynamics make?

AngioDynamics (NASDAQ:ANGO) has a market capitalization of $423.40 million and generates $316.22 million in revenue each year. The medical instruments supplier earns $-26,550,000.00 in net income (profit) each year or ($0.94) on an earnings per share basis.

How many employees does AngioDynamics have?

The company employs 800 workers across the globe.

Does AngioDynamics have any subsidiaries?
The following companies are subsidiares of AngioDynamics: AngioDynamics Canada Inc., AngioDynamics France SARL, AngioDynamics Medical Brasil Participacoes Ltda., AngioDynamics Netherlands B. V., AngioDynamics UK Limited, AngioDynamics VA LLC, Clinical Devices, Eximo Medical Ltd., FlowMedica, NM Holding Company Inc., Navilyst Medical Holdings Inc., Navilyst Medical Inc., Oncovionic, RITA Medical Systems, RITA Medical Systems LLC, RadiaDyne LLC, and Vortex Medical.
Read More
How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The official website for the company is www.angiodynamics.com. The medical instruments supplier can be reached via phone at (518) 795-1400, via email at mpolyviou@evcgroup.com, or via fax at 518-795-1401.

This page (NASDAQ:ANGO) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -